Nanobiotix S A 's ability to collect its outstanding accounts receivable from its corporate clients, has improved in the fourth quarter 2025 to a ratio of 15.26, above the company average. This is a clear sign of healthy business climate in the Major Pharmaceutical Preparations industry and improving liquidity at their respective customers, during the fourth quarter 2025. Nanobiotix S A 's Accounts Receivable average collection period in the Dec 31 2025 quarter, has decreased to 24 days, from -119 days, in the 0 quarter.

If we take a look into Healthcare sector 298 other companies have achieved higher receivables turnover ratio. While total ranking has deteriorated relative to the period ending Dec 31 2025 from 0 to 2190.

What is Receivable Turnover Ratio?
What is Nanobiotix S A Selling?

What is Receivable Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Accounts Receivables Turnover▼

None ▼

Accounts Receivables Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

NBTX Receivables Turnover Ratio	(Dec 31 2025) IV. Quarter	0 III. Quarter	0 II. Quarter	0 I. Quarter	(Dec 31 2024) IV. Quarter
Y / Y Receivable Change	-28.25 %	-28.25 %	-28.25 %	-28.25 %	228.95 %
Y / Y Revenue Change	-	-	-	-	-
Receivable Turnover Ratio (TTM)	15.26	-	-	-	-
NBTX's Total Ranking	# 2190	# 0	#	#	#
Accounts Receivable average collection period days	24	-	-	-	-
Seq. Receivable Change	0 %	0 %	0 %	-28.25 %	0 %
Seq. Revenue Change	-	-	-	-	-

Receivable Turnover Company Ranking
Within:	No.
Major Pharmaceutical Preparations Industry	# 88
Healthcare Sector	# 299
Overall Market	# 2190

Receivable Turnover Ratio Statistics
High	Average	Low
0.48	0.15	-0.11
(Dec 31 2025)		(Dec 31 2024)

NBTX Company Profile • Back to NBTX Efficiency Comparisons • Compare NBTX Receivables Turnover Ratio to its Competitors

Financial Statements
Nanobiotix S A 's Accounts Receivable	$ 2 Millions	Visit NBTX's Balance sheet
Nanobiotix S A 's Sales TTM	$ 37 Millions	Visit NBTX's Income Statement
Sources of NBTX's Revenues		Visit NBTX's Sales by Geography

Other Accounts Receivable Turnover Ratios
Major Pharmaceutical Preparations Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
NBTX's Receivable Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
NBTX's Growth Rates	NBTX's Roa	NBTX's Inventory Turnover Ratio	NBTX's Dividend Comparisons
NBTX's Profitability Ratios	NBTX's Roi	NBTX's Asset Turnover Ratio	NBTX's Dividend Growth
NBTX's Valuation Ratios	NBTX's Roe	NBTX's Financial Strength Ratios	NBTX's Dividend Payout Ratio

Companies with similar Receivables Turnover Ratio for the quarter ending Dec 31 2025, within Healthcare Sector	Receivable Turnover Ratio	Revenues for 12 Months ending Dec 31 2025	Receivable at quarter ending Dec 31 2025
Kyntra Bio Inc	41.55	$ 6.440 Millions	$ 0.155 Millions
Cytomx Therapeutics Inc	40.82	$ 76.201 Millions	$ 1.867 Millions
Atara Biotherapeutics Inc	40.31	$ 121.355 Millions	$ 3.010 Millions
Nature s Sunshine Products inc	39.85	$ 479.724 Millions	$ 12.040 Millions
National Vision Holdings Inc	39.24	$ 1,987.488 Millions	$ 50.646 Millions
Lineage Cell Therapeutics Inc	39.16	$ 14.556 Millions	$ 0.372 Millions
Meiragtx Holdings Plc	36.74	$ 81.391 Millions	$ 2.215 Millions
Marpai Inc	36.38	$ 18.099 Millions	$ 0.497 Millions
Premier Air Charter Holdings Inc	34.28	$ 31.878 Millions	$ 0.930 Millions
Metagenomi Therapeutics Inc	32.01	$ 25.210 Millions	$ 0.788 Millions
U S Physical Therapy Inc	30.83	$ 780.990 Millions	$ 25.331 Millions
Prenetics Global Limited	30.82	$ 91.790 Millions	$ 2.978 Millions
Invo Fertility Inc	30.16	$ 6.841 Millions	$ 0.227 Millions
Innovative Eyewear Inc	28.53	$ 2.662 Millions	$ 0.093 Millions
Newgenivf Group Limited	28.38	$ 4.726 Millions	$ 0.167 Millions
Electrocore Inc	26.63	$ 31.800 Millions	$ 1.194 Millions
Innovage Holding Corp	26.09	$ 915.371 Millions	$ 35.080 Millions
Polomar Health Services, Inc.	25.80	$ 0.648 Millions	$ 0.025 Millions
Keros Therapeutics Inc	25.67	$ 257.786 Millions	$ 10.042 Millions
Cv Sciences Inc	25.56	$ 11.388 Millions	$ 0.446 Millions
Euda Health Holdings Limited	24.44	$ 5.993 Millions	$ 0.245 Millions
Longeveron Inc	22.20	$ 1.199 Millions	$ 0.054 Millions
Lifemd Inc	21.48	$ 193.686 Millions	$ 9.018 Millions
Fonar Corporation	21.42	$ 106.031 Millions	$ 4.950 Millions
Neuraxis Inc	21.11	$ 3.569 Millions	$ 0.169 Millions
Biorestorative Therapies Inc	20.88	$ 0.360 Millions	$ 0.017 Millions
Voyager Therapeutics Inc	19.59	$ 40.374 Millions	$ 2.061 Millions
Sonida Senior Living Inc	19.55	$ 381.141 Millions	$ 19.494 Millions
Siga Technologies Inc	19.47	$ 94.575 Millions	$ 4.856 Millions
Kiniksa Pharmaceuticals International Plc	19.45	$ 677.564 Millions	$ 34.828 Millions

Date modified: 2026-09-18T13:11:06+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.